Prof Bryan Hennessy

1 result

Dr Michael O’Neill, director of research and development at Inflection Biosciences, Darren Cunningham, chief executive at Inflection and Prof Bryan Hennessy, senior clinical lecturer at RCSI and consultant medical oncologist. Photograph: Julien Behal
Irish company to showcase ‘breakthrough’ breast cancer drug

Irish drug development company Inflection Biosciences will present data on its fledgling breakthrough breast cancer therapy to the American Associatio(...)